ESTUDIO ALEATORIZADO, DOBLE CIEGO, CONTROLADO POR PLACEBO, DE 52 SEMANAS DE DURACIÓN PARA EVALUAR LOS ACONTECIMIENTOS ADVERSOS DE ESPECIAL INTERÉS EN ADULTOS CON LUPUS ERITEMATOSO SISTÉMICO ACTIVO, CON AUTOANTICUERPOS POSITIVOS, QUE TOMAN BELIMUMAB.

Meeting Abstract. 10.1136/annrheumdis-2021-eular.3114. 2021

ANTIMALARIAL DRUGS AND ELECTROCARDIOGRAPHIC ALTERATIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS.

Barcena, C. Riesco; (...); Roman Ivorra, J. A.

Meeting Abstract. 10.1136/annrheumdis-2022-eular.2847. 2022

Antimicrobial stewardship programme implementation in a medical ward

Ruiz, J; (...); Poveda, JL

Article. 2018

Antimicrobial stewardship programme in critical care medicine: A prospective interventional study

Ruiz, J; (...); Catellanos, A

Article. 10.1016/j.medin.2017.07.002. 2018

ANTI-RO52 KDa and ANTI-RO60 KDa Analysis in Systemic LUPUS Erythematous Patients to Detect ANTI-RO False-Negatives

Meeting Abstract. 2017

ANTI-RO52 KDA AND ANTI-RO60 KDA ANALYSIS IN SYSTEMIC LUPUS ERYTHEMATOUS PATIENTS TO DETECT ANTI-RO FALSE-NEGATIVES

Meeting Abstract. 10.1136/annrheumdis-2017-eular.5758. 2017

Apremilast for Refractory Mucocutaneous Ulcers of Behcet's Disease. National Multicenter Study of 14 Cases

Atienza-Mateo, B; (...); Blanco, R

Meeting Abstract. 2017

Apremilast in Combination vs Monotherapy for Refractory Oral And/or Genital Ulcers in Behcet's Disease: National Multicenter Study of 51 Cases

Atienza-Mateo, Belen; (...); Blanco, Ricardo

Meeting Abstract. 2019

APREMILAST IN MONOTHERAPY OR COMBINED IN NON-ULCER MANIFESTATIONS OF BEHCET'S DISEASE. NATIONAL MULTICENTER STUDY OF 34 REFRACTORY CASES OF CLINICAL PRACTICE

Morant, AH; (...); Blanco, R.

Meeting Abstract. 10.1136/annrheumdis-2020-eular.4720. 2020

Apremilast in Refractory Oral and/or Genital Ulcers in Behcet's Disease. Multicenter Study of 37 Cases

Atienza-Mateo, B; (...); Blanco, R

Meeting Abstract. 2018

Apremilast in refractory orogenital ulcers and other manifestations of Behcet's disease. A national multicentre study of 51 cases in clinical practice

Atienza-Mateo, B.; (...); Blanco, R.

Article. 2020

Apremilast in refractory orogenital ulcers and other manifestations of Behçet's disease. A national multicentre study of 51 cases in clinical practice.

Atienza-Mateo B; (...); Blanco R

Article. 2020

Aqueous Humor Levels of Different Interleukins 1-beta, 2, 6 and 10, Tumor Necrosis Factor-alpha and Vascular Endothelial Growth Factor in Uveitis Treated with Adalimumab.

Hernandez Garfella ML; (...); Cervera Taulet E

Article. 10.4103/2008-322X.156110. 2015

ASSESMENT OF CLINICAL AND RADIOLOGICAL PROGNOSTIC VARIABLES IN PATIENTS WITH SPONDYLODISCITIS

Gil, JJF; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2017-eular.5891. 2017

Assessing the value of moderate-to-severe atopic dermatitis treatment using multi-criteria decision analysis (MCDA).

Pereyra-Rodríguez JJ; (...); Ortiz de Frutos FJ

Letter. 10.1111/jdv.19432. 2023

Assessment of the quality of sample labelling for clinical research.

Pérez-Huertas P; (...); Poveda-Andrés JL

Article. 10.7399/fh.2016.40.2.9753. 2016

ASSOCIATION BETWEEN CARDIOVASCULAR RISK FACTORS AND CAROTID INTIMA-MEDIA THICKNESS IN PATIENTS WITH RHEUMATOID ARTHRITIS

Mazario, RG; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2017-eular.5868. 2017

Association of Anti-CarP Levels with Clinical Activity and Serological Profile in Rheumatoid Arthritis

Martinez Calabuig, Pablo; (...); Roman-Ivorra, Jose A.

Meeting Abstract. 2024

Association of SNPs with the efficacy and safety of immunosuppressant therapy after heart transplantation

Sánchez-Lázaro I; (...); Aliño SF

Article. 10.2217/pgs.15.39. 2015

AUTOANTIBODY PROFILE ANALYSIS AND ITS ASSOCIATION WITH CLINICAL MANIFESTATIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS

Meeting Abstract. 10.1136/annrheumdis-2019-eular.5699. 2019

Autologous stem cell transplantation in systemic sclerosis: 4 cases.

de la Rubia Navarro, Marta, Leal Rodriguez, Samuel, Roman Ivorra, Jose Andres

Article. 10.1016/j.reumae.2025.501810. 2025

Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients.

Iglesias Gómez R; (...); Poveda Andrés JL

Article. 10.1136/ejhpharm-2021-002741. 2021

BASELINE PROFILE OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS ON TREATMENT WITH BELIMUMAB OF A SPANISH MULTICENTER COHORT

Altabas Gonzalez, I.; (...); Rua-Figueroa, I.

Meeting Abstract. 10.1136/annrheumdis-2023-eular.3003. 2023

Bayesian pharmacokinetic individualization of prophylaxis with recombinant factor VIII in severe or moderate hemophilia A

Megias-Vericat, JE; (...); Bonanad, S

Meeting Abstract. 2018

Bayesian pharmacokinetic-guided prophylaxis with recombinant factor VIII in severe or moderate haemophilia A

Poveda-Andrés JL, Bosó-Ribelles V

Article. 10.1016/j.thromres.2018.12.027. 2019

BELIMUMAB IV EFFECT IN GLUCOCORTICOID TREATMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS

Navarro, MD; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2019-eular.6585. 2019

Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study.

Fernandez Rivera C; (...); Hernandez D

Article. 10.1111/ctr.14550. 2022

Biosimilares: viejas polemicas con nuevos argumentos.

Editorial Material. 10.7399/fh.2015.39.3.8978. 2015

BK Virus-Associated Hemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplantation in the Pediatric Population

Perez-Huertas, P; (...); Poveda-Andres, JL

Article. 10.1177/1043454216631952. 2017

BLYS UPREGULATION IS RELATED TO LYMPHOPENIA IN SYSTEMIC ERYTHEMATOUS LUPUS PATIENTS

Meeting Abstract. 10.1136/annrheumdis-2017-eular.4186. 2017

BONE METABOLISM AND OSTEOPOROSIS RISK FACTORS ANALYSIS IN SPINAL CORD INJURY PATIENTS

Grau Garcia, E.; (...); Roman Ivorra, J.

Meeting Abstract. 10.1136/annrheumdis-2016-eular.5086. 2016

BONE METABOLISM AND OSTEOPOROSIS RISK FACTORS ANALYSIS IN SPINAL CORD INJURY PATIENTS AT TWELVE MONTHS FOLLOW UP

Cordellat, IM; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2017-eular.5487. 2017

BONE Metabolism in LIVER Transplant Patients Two-Year Study. Influence of Medical Intervention PRIOR to Surgery and Antiresorptive Treatment

Sanchez, EL; (...); Ivorra, JAR

Meeting Abstract. 2017

BONE METABOLISM IN LIVER TRANSPLANT PATIENTS TWO-YEAR STUDY. INFLUENCE OF MEDICAL INTERVENTION PRIOR TO SURGERY AND ANTIRESORPTIVE TREATMENT

Sanchez, EL; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2017-eular.5855. 2017

Breakthrough invasive fungal disease in high-risk hematologic malignancies in children: a single-center experience

Garcia-Robles, AA; (...); Fernandez-Navarro, JM

Meeting Abstract. 2017

Calidad y Legibilidad de la Hoja de Informacion al Paciente en Estudios con Analisis Farmacogenetico.

Ruiz Ramos J; (...); Poveda Andrés JL

Article. 2015

CAPILLAROSCOPY: A USEFUL TOOL FOR IDENTIFYING PRIMARY RAYNAUD

Martinez Cordellat, I.; (...); Roman Ivorra, J. A.

Article. 10.1136/annrheumdis-2014-eular.4985. 2014

Cardiovascular Risk Assessment with Carotid Ultrasonography in Addition to the Traditional Cardiovascular Risk Factor in Rheumatoid Arthritis: A Case Control Study

Mazario, RG; (...); Ivorra, JAR

Meeting Abstract. 2020

CARDIOVASCULAR RISK ASSESSMENT WITH CAROTID ULTRASONOGRAPHY IN ADDITION TO THE TRADITIONAL CARDIOVASCULAR RISK FACTORS IN RHEUMATOID ARTHRITIS PATIENTS: A CASE CONTROL STUDY

Mazario, RG; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2020-eular.6420. 2020

Cardiovascular risk assessment with carotid ultrasound in rheumatoid arthritis.

González Mazarío R; (...); Román Ivorra JA

Article. 10.1016/j.medcli.2022.01.017. 2022

CLINICAL AND SEROLOGICAL EVOLUTION OF RHEUMATIC PATIENTS INFECTED BY SARS-COV-2

Navarro, M. De la Rubia; (...); Ivorra, J. A. Roman

Meeting Abstract. 10.1136/annrheumdis-2022-eular.4559. 2022

Clinical benefits of a Bayesian model for plasma-derived factor VIII/VWF after one year of pharmacokinetic-guided prophylaxis in severe/moderate hemophilia A patients

Article. 10.1016/j.thromres.2021.07.009. 2021

Clinical evaluation of rituximab treatment for neuromyelitis optica

Fernández-Megía MJ; (...); Poveda-Andrés JL

Article. 10.1016/j.nrl.2014.09.001. 2015

Clinical experiences with cannabinoids in spasticity management in multiple sclerosis

Lorente Fernández L; (...); Casanova-Estruch B

Article. 10.1016/j.nrl.2013.06.014. 2014

Clinical pharmacy services: from cost-effectiveness analysis to a productivity indicators model

Nogueras, A; (...); Calleja, MA

Letter. 10.1136/ejhpharm-2019-001905. 2019

Clinical trials: their contribution to the efficiency of the clinical management of rheumatoid arthritis.

Escandell CPA, Ivorra JAR

Article. 10.7573/dic.212612. 2019

CLINICAL VARIABILITY IN PATIENTS DIAGNOSED OF JUVENILE IDIOPATHIC ARTHRITIS WITH POSITIVE AND NEGATIVE ANTINUCLEAR ANTIBODIES (ANA)

Torrat Noves, A. M.; (...); Roman Ivorra, J. A.

Meeting Abstract. 10.1136/annrheumdis-2023-eular.5203. 2023

Collaborative model of home delivery program in haemophilia through an association of patients

Megias-Vericat, JE; (...); Bonanad, S

Meeting Abstract. 2018

COMORBIDITY CLUSTERS AND THEIR RELATIONSHIP WITH SEVERITY AND OUTCOMES OF THE INDEX DISEASES, IN A LARGE MULTICENTER SYSTEMIC LUPUS ERYTHEMATOSUS COHORT (RELESSER REGISTER)

Rua-Figueroa, I.; (...); Pego-Reigosa, J. M.

Meeting Abstract. 10.1136/annrheumdis-2023-eular.4168. 2023

Comparison between Tocilizumab Prescribed As Monotherapy Versus Combined with Conventional Immunosuppressant Agents in Giant Cell Arteritis Patients

Goercke, MC; (...); Blanco, R

Meeting Abstract. 2018

Comparison of pharmacokinetic estimates using generic and specific population pharmacokinetic models of plasma-derived factor VIII/VWF using WAPPS-Hemo

Meeting Abstract. 2020

Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice

Bykerk, VP; (...); Sibilia, J

Article. 10.1007/s10067-014-2857-y. 2015

COMPUTER TOMOGRAPHY GUIDED BIOPSY YIELD IN PYOGENIC VERTEBRAL OSTEOMYELITIS. AN EXAMINATION OF INFLUENCING FACTORS

Fragio-Gil, JJ; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2019-eular.6627. 2019

Concordance Between the QuantiFERON-TB Gold In-Tube and Tuberculin Test for the Diagnosis of Latent Tuberculosis Infection in Patients with Rheumatic Diseases

Perales, CP; (...); Ivorra, JAR

Meeting Abstract. 2020

CONCORDANCE BETWEEN THE QUANTIFERON-TB GOLD IN-TUBE AND TUBERCULIN TEST FOR THE DIAGNOSIS OF LATENT TUBERCULOSIS INFECTION IN PATIENTS WITH RHEUMATIC DISEASES

Perales, CP; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2021-eular.3157. 2021

Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.

Montoro-Ronsano JB; (...); Soto-Ortega I

Article. 10.1016/j.farma.2023.01.003. 2023

Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.

Montoro-Ronsano, Jose Bruno; (...); Soto-Ortega, Inmaculada

Article. 10.1016/j.farma.2023.04.002. 2023

CONTRIBUTION OF CLINICAL TRIALS TO THE EFFICIENCY OF ARTHRITIS RHEUMATOID MANAGEMENT

Escandell, CA; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2017-eular.6082. 2017

CORRELATION BETWEEN PATIENT-REPORTED OUTCOMES OF HEALTH-RELATED QUALITY OF LIFE AND CLINICAL ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS

Meeting Abstract. 10.1136/annrheumdis-2019-eular.5661. 2019

Corrigendum to "Relationship between structural damage with loss of strength and functional disability in psoriatic arthritis patients" [Clin. Biomech. volume 68 (2019) Pages 169-174/Article Number JCLB 4795].

Olmos CMF; (...); Ivorra JAR

Correction. 10.1016/j.clinbiomech.2019.10.023. 2020

Cost analysis of biologic drugs in rheumatoid arthritis first line treatment aftermethotrexate failure according to patients' body weight

Roman Ivorra JA; (...); Gomez-Barrera M

Article. 10.1016/j.reuma.2015.07.008. 2016

COST MINIMIZATION ANALYSIS OF RITUXIMAB BIOSIMILAR VERSUS REFERENCE RITUXIMAB IN THE TREATMENT OF FOLLICULAR LYMPHOMA

Gironella, M.; (...); Oyaguez, I

Meeting Abstract. 2019

COST-EFFECTIVENESS ANALYSIS OF DIFELIKEFALIN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE ASSOCIATED-PRURITUS IN SPAIN

Sanchez-Alvarez, Emilio E.; (...); Hernaez Colque, M.

Meeting Abstract. 2024

Cost-effectiveness analysis of implementing an antimicrobial stewardship program in critical care units

Ruiz-Ramos, J; (...); Ramirez, P

Article. 10.1080/13696998.2017.1311903. 2017

Cost-effectiveness of Cladribine Tablets and fingolimod in the treatment of relapsing multiple sclerosis with high disease activity in Spain.

Poveda JL; (...); Torres C

Article. 10.1080/14737167.2019.1635014. 2020

COST-EFFECTIVENESS OF CLADRIBINE TABLETS AND FINGOLIMOD IN THE TREATMENT OF REMITTING MULTIPLE SCLEROSIS WITH HIGH DISEASE ACTIVITY IN SPAIN

Trillo, JL; (...); Torres, C

Meeting Abstract. 10.1016/j.jval.2018.09.2029. 2018

Cost-effectiveness of methoxy polyethylene glycolepoetin beta versus conventional epoetin in the treatment of anaemia secondary to chronic kidney disease in clinical practice

Lorente-Fernandez, L; (...); Poveda-Andres, JL

Article. 10.1136/ejhpharm-2013-000426. 2015

COSTS OF THE MANAGEMENT OF HEMOPHILIA A WITH INHIBITORS IN SPAIN

Bonanad, S; (...); Gonzalez-Dominguez, A

Meeting Abstract. 2020

Costs of the management of hemophilia A with inhibitors in Spain

Bonanad, S; (...); Gonzalez-Dominguez, A

Article. 10.33393/grhta.2021.2234. 2021

COVID-19 AND JAKI: ANALYSIS AFTER THREE-YEAR PANDEMIC AT A SPANISH TERTIARY CARE HOSPITAL

Munoz Martinez, P.; (...); Roman Ivorra, J. A.

Meeting Abstract. 10.1136/annrheumdis-2023-eular.4263. 2023

Cranial and extracranial giant cell arteritis do not exhibit differences in the IL6 -174 G/C gene polymorphism.

Genre, F.; (...); Gonzalez-Gay, M. A.

Article. 10.55563/clinexprheumatol/cbjnmo. 2023

Cranial and extracranial giant cell arteritis share similar HLA-DRB1 association

Prieto-Pena, D; (...); Gonzalez-Gay, MA

Article. 10.1016/j.semarthrit.2020.07.004. 2020

Cross-sectional comparative study of pharmacokinetics and efficacy between sucrose-formulated recombinant factor VIII (Kogenate (R)) and BAY 81-8973 (KovaltryA (R)) in patients with severe or moderate haemophilia A in prophylaxis

Letter. 10.1111/hae.13733. 2019

Cross-Sectional Comparative Study of PK-Guided Switch between Standard Half-Life and Extended Half-Life Factor VIII Products

Eduardo Megias, Juan; (...); Iorio, Alfonso

Meeting Abstract. 10.1182/blood-2019-127946. 2019

CT GUIDED NEEDLE BIOPSY IN VERTEBRAL OSTEOMYELITIS: RELIABILITY ANALYSIS AND STUDY OF WHICH FACTORS COULD INFLUENCE ON THE RESULT

Fragio-Gil, J. J.; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2020-eular.6383. 2020

CT-Guided Needle Biopsy in Vertebral Osteomyelitis: Study of Factors That Could Influence in Culture Yield.

Fragío Gil JJ; (...); Román Ivorra JA

Article. 10.1016/j.reumae.2020.08.007. 2022

CT-Guided Needle Biopsy in Vertebral Osteomyelitis: Study of Factors That Could Influence in Culture Yield

Fragio Gil, Jorge Juan; (...); Roman Ivorra, Jose Andres

Article. 10.1016/j.reuma.2020.08.002. 2022

Current Status of Multidisciplinary Care in Psoriatic Arthritis in Spain: NEXUS 2.0 Project.

Queiro R; (...); Gratacos J

Article. 10.1016/j.reuma.2018.01.010. 2020

Cybersecurity, a priority for pharmacy services in the age of artificial intelligence.

Hernández Marín CM, Monte-Boquet E, Poveda Andrés JL

Editorial Material. 10.1016/j.farma.2024.08.001. 2024

Daunorubicin and cytarabine for certain types of poor-prognosis acute myeloid leukemia: a systematic literature review

Megias-Vericat, JE; (...); Montesinos, P

Review. 10.1080/17512433.2019.1573668. 2019

Decreased DNA hydroxymethylation and increased DNA demethylation are associated with high antioxidant response in systemic lupus erythematosus patients.

Fragío Gil JJ; (...); Román Ivorra JA

Case Reports. 10.1016/j.medcli.2020.10.023. 2021

Defining a set of standardised outcome measures for newly diagnosed patients with multiple myeloma using the Delphi consensus method: the IMPORTA project

Blade, J; (...); Lizan, L

Article. 10.1136/bmjopen-2017-018850. 2018

Design and rationale for a real-world prospective, multicenter registry of myocardial revascularization failure and secondary revascularization: The REVASEC study.

Salinas P; (...); Escaned J

Article. 10.1016/j.carrev.2021.11.015. 2021

Determining the value contribution of emicizumab (Hemlibra (R)) for the prophylaxis of haemophilia A with inhibitors in Spain by multi-criteria decision analysis

Alvarez-Roman, MT; (...); Badia, X

Article. 10.1177/2284240319880534. 2019

DETERMINING THE VALUE OF EMICIZUMAB FOR THE PROPHYLAXIS OF SEVERE HAEMOPHILIA A PATIENTS WITHOUT INHIBITORS IN SPAIN BY MULTI-CRITERIA DECISION ANALYSIS (MCDA)

Alvarez, E.; (...); Badia, F. J.

Meeting Abstract. 2019

Determining value in the treatment of activated PI3Kdelta syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders.

Abad, Maria Reyes; (...); Gil, Alicia

Article. 10.33393/grhta.2024.3041. 2024

Determining what represents value in the treatment of prurigo nodularis and its key unmet needs in Spain through Multi-Criteria Decision Analysis

Silvestre, Juan Francisco; (...); Serra-Baldrich, Esther

Article. 10.1002/jvc2.275. 2024

DEVELOPMENT AND VALIDATION OF A MCDA FRAMEWORK FOR EVALUATION AND DECISION-MAKING OF ORPHAN DRUGS IN SPAIN

Poveda, J. L.; (...); Vitoria, I

Meeting Abstract. 2019

Development and validation of an MCDA framework for evaluation and decision-making of orphan drugs in Spain

Badia, X; (...); Poved, JL

Article. 10.1080/21678707.2019.1652163. 2019

Development of an application for mobile phones (App) based on the collaboration between the Spanish Society of Rheumatology and Spanish Society of Family Medicine for the referral of systemic autoimmune diseases from primary care to rheumatology.

Urruticoechea-Arana A; (...); Rúa-Figueroa Í

Article. 10.1016/j.reuma.2019.09.001. 2019

Development of psoriasis in a patient with reumatoid arthritis after rituximab

Olmos, CMF; (...); Ivorra, JAR

Letter. 10.1016/j.medcli.2013.01.024. 2014

Diagnosis of Giant Cell Arteritis in Spain: Data from the ARTESER Registry

De Miguel, Eugenio; (...); Blanco, Ricardo

Meeting Abstract. 2021

DIFFERENCES IN BONE METABOLISM BETWEEN INTERMITTENT AND CONTINUOUS TREATMENT WITH LHRH AGONISTS IN PROSTATE CANCER PATIENTS

Arevalo, KR; (...); Roman, JA

Meeting Abstract. 10.1136/annrheumdis-2018-eular.6948. 2018

Differences in BONE Metabolism between Intermittent and Continuous Treatment with LHRH Agonists in Prostate Cancer Patients

Ruales, KA; (...); Ivorra, JAR

Meeting Abstract. 2017

DNA HYPOMETHYLATION AND DECREASED HYDROXYMETHYLATION IS ASSOCIATED WITH DECREASED ANTIOXIDANT RESPONSE IN SYSTEMIC LUPUS ERYTHEMATOUS PATIENTS

Garcia, EG; (...); Lvorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2017-eular.2905. 2017

Do antiTNF or Ustekinumab trough levels correlate with joint extraintestinal manifestations activity in Inflammatory bowel disease patients?

Madero Velazquez, L.; (...); Gutierrez Casbas, A.

Meeting Abstract. 2024

Do antiTNF through levels correlate with joint extraintestinal manifestations (EIM) activity in Inflammatory bowel disease (IBD) patients?

Madero Velazquez, L.; (...); Gutierrez Casbas, A.

Meeting Abstract. 2023

Dose banding aplicado a la elaboracion de antineoplasicos: una revision narrativa de la literatura.

Pérez Huertas P; (...); Poveda Andrés JL

Article. 10.7399/fh.2015.39.4.8839. 2015

Drug Interaction Between Oral Cyclosporine Modified and Iron

Domingo-Chiva, E; (...); Poveda-Andres, JL

Article. 10.1177/1060028013514734. 2014

Early experience with compassionate use of 2 hydroxypropyl-beta-cyclodextrin for Niemann-Pick type C disease: review of initial published cases

Review. 10.1007/s10072-017-2833-9. 2017

ECONOMIC IMPACT LINKED TO THE REDUCTION OF EXACERBATIONS WHEN A TREATMENT REGIME WITH INHALED ANTIBIOTICS IS SWITCHED TO AZTREONAM LYSINE IN PATIENTS WITH CYSTIC FIBROSIS AND CHRONIC PULMONARY INFECTION CAUSED BY PSEUDOMONAS AERUGINOSA

Sole A; (...); Casado MA

Meeting Abstract. 10.1016/j.jval.2014.08.1659. 2014

Economic impact of optimising antiretroviral treatment in human immunodeficiency virus-infected adults with suppressed viral load in Spain, by implementing the grade A-1 evidence recommendations of the 2015 GESIDA/National AIDS Plan

Ribera, E; (...); Hernandez-Novoa, B

Article. 10.1016/j.eimc.2016.11.015. 2018

Efectiveness of belimumab in the treatment of lupus nephritis: analysis of 8 cases.

de la Rubia Navarro, Marta; (...); Roman Ivorra, Jose Andres

Article. 10.1016/j.medcli.2022.05.003. 2022

Efecto de la adición de fortificantes y de módulo de proteínas en la osmolalidad de la leche materna donada.

Torres Martínez E; (...); Vento M

Article. 10.1016/j.anpedi.2020.03.009. 2020

EFFECT OF CYP3A5 GENOTYPE ON TACROLIMUS DOSE REQUIREMENT, NEPHROTOXICITY AND ACUTE REJECTION IN KIDNEY TRANSPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF OBSERVATIONAL STUDIES

Rojas, L.; (...); Alino, S. F.

Article. 2013

Effect of CYP3A5*3 on kidney transplant recipients treated with tacrolimus: a systematic review and meta-analysis of observational studies

Rojas L; (...); Aliño SF

Article. 10.1038/tpj.2014.38. 2015

Effect of different schemes of androgen deprivation therapy on bone mass density in prostate cancer patients.

Arevalo Ruales, Karla; (...); Roman Ivorra, Jose Andres

Article. 10.1016/j.medcli.2022.03.026. 2023

EFFECTIVENESS OF BELIMUMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS OF A MULTICENTER SPANISH COHORT

Altabas Gonzalez, I.; (...); Rua-Figueroa, I.

Meeting Abstract. 10.1136/annrheumdis-2023-eular.3482. 2023

Effectiveness of Caplacizumab Nanobody in Acquired Thrombotic Thrombocytopenic Purpura Refractory to Conventional Treatment

Palanques-Pastor T; (...); Poveda Andrés JL

Article. 10.1159/000517813. 2021

Effectiveness of Tocilizumab in Cranial and Extracranial Phenotypes of Giant Cell Arteritis: Multicenter Study of 471 Cases

Sanchez-Bilbao, Lara; (...); Blanco, Ricardo

Meeting Abstract. 2021

Effectiveness of Tocilizumab in the Visual Involvement of Giant Cell Arteritis: Multicenter Study of 471 Patients of Clinical Practice

Sanchez-Bilbao, Lara; (...); Blanco, Ricardo

Meeting Abstract. 2021

EFFECTS OF POLYMORPHIMS OF CYP3A5 AND ABCB1 GENES ON CHRONIC NEPHROPATHY: COHORT STUDY

Rojas, L.; (...); Alino, S. F.

Article. 2013

EFFICACY AND SAFETY OF APREMILAST IN BEHCET DISEASE PATIENTS

Bernabeu, EV; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2020-eular.5330. 2020

EFFICACY AND SAFETY OF BARICITINIB AND TOFACITINIB IN RHEUMATOID ARTHRITIS: DATA FROM REAL-WORLD

Mazario, RG; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2020-eular.6321. 2020

Efficacy of Raynaud's phenomenon and digital ulcer pharmacological treatment in systemic sclerosis patients: a systematic literature review

Lefebvre, PGD; (...); Munoz-Fernandez, S

Review. 10.1007/s00296-015-3241-1. 2015

Efficacy of Tocilizumab in Giant Cell Arteritis, Independent of the Time of Disease Evolution

Calderon-Goercke, Monica; (...); Blanco, Ricardo

Meeting Abstract. 2019

Efficacy of tocilizumab monotherapy after response to combined tocilizumab and methotrexate in patients with rheumatoid arthritis: the randomised JUST-ACT study

Pablos, JL; (...); Rivero, N

Article. 2019

eLearning of pharmacokinetic monitoring in hemophilia with application in the clinical practice

Bonanad, S; (...); Megias-Vericat, JE

Meeting Abstract. 2018

Eosinophilic Granulomatosis with Polyangiitis: Clinical Suspicion Red Flags Identification by a Systematic Literature Review and Multidisciplinary Expert Consensus

Blanco, Ricardo; (...); Alvaro-Gracias, Jose Maria

Meeting Abstract. 2023

EPIDEMIOLOGY, DIAGNOSIS AND CLINICAL CHARACTERISTICS OF GIANT CELL ARTERITIS IN PATIENTS INCLUDED IN THE ARTESER MULTICENTER STUDY

Sanchez-Costa, J. T.; (...); Blanco, R.

Meeting Abstract. 10.1136/annrheumdis-2022-eular.1313. 2022

Erratum corrige: "Efficacy of tocilizumab monotherapy after response to combined tocilizumab and methotrexate in patients with rheumatoid arthritis: the randomised JUST-ACT study". J.L. Pablos et al.

Pablos JL; (...); Rivero N

Correction. 2020

Estudio de utilizacion de boceprevir y telaprevir para el tratamiento de la hepatitis C cronica.

Marrero-Álvarez P; (...); Poveda-Andrés JL

Abstract of Published Item. 10.7399/FH.2014.38.1.1128. 2014

EVALUATING REAL LIFE CRITERIA THAT COULD DRIVE PRICING & REIMBURSEMENT (P&R) APPROVAL OF ORPHAN DRUGS (ODS) IN SPAIN

Badia, F. J.; (...); Shepherd, J.

Meeting Abstract. 2019

EVALUATION OF CUMULATIVE DAMAGE IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS AS A NEW CARDIOVASCULAR RISK FACTOR

Fernandez Matilla, M.; (...); Roman Ivorra, J.

Meeting Abstract. 10.1136/annrheumdis-2016-eular.4119. 2016

Evaluation of the impact of nursing clinics in the rheumatology services

Munoz-Fernandez, S; (...); Lazaro, P

Article. 10.1007/s00296-016-3518-z. 2016

EXPERIENCE IN REAL-WORLD CONDITIONS OF THE EFFECTIVENESS OFTHEVACCINE AGAINST HERPES ZOSTER

Mas Sanchez, L.; (...); Roman Ivorra, J. A.

Meeting Abstract. 10.1136/annrheumdis-2023-eular.4258. 2023

Experience in the management of immunosuppressant treatment with hepatitis C virus protease inhibitors

Ruiz Ramos J; (...); Poveda Andrés JL

Article. 10.1016/j.gastrohep.2014.05.004. 2014

Experience of Home Delivery Program in Haemophilia Through an Association of Patients

Megias Vericat, J. E.; (...); Bonanad Boix, S.

Meeting Abstract. 2017

Expert Recommendations on the Interleukin 6 Blockade in Patients with Rheumatoid Arthritis.

Tornero Molina, Jesus; (...); Sanmarti, Raimon

Article. 10.1016/j.reuma.2018.07.004. 2018

EXPERTS CONSENSUS ON THE FUTURE OF RARE DISEASES CARE AND ORPHAN DRUGS ACCESS IN SPAIN: A DELPHI STUDY

Paz S; (...); Urcelay J

Meeting Abstract. 10.1016/j.jval.2015.09.2016. 2015

Exploratory analysis for the implementation of antineoplastic logarithmic dose banding

Albert-Mari, A; (...); Poveda-Andres, JL

Article. 10.1007/s11096-018-0714-9. 2018

EXTENDED MULTICRITERIA DECISION ANALYSIS IN DIABETIC MACULAR EDEMA. MULTIDEX-EMD EXTENSION STUDY

F, de Andres-Nogales; (...); Martinez, M.

Meeting Abstract. 2019

Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn's Disease

Beltran, B; (...); Nos, P

Article. 10.1159/000492626. 2019

Fetal exposure to tofacitinib during the first trimester: A healthy newborn case report

Fernandez-Sanchez, M; (...); Poveda-Andres, JL

Article. 10.1002/bdr2.1942. 2021

FREQUENCY OF POLYAUTOIMMUNITY IN A TERTIARY HOSPITAL

Meeting Abstract. 10.1136/annrheumdis-2019-eular.5582. 2019

Genetic Variants Associated with Biological Treatment Response in Inflammatory Bowel Disease: A Systematic Review.

Plaza J; (...); Moret-Tatay I

Article. 10.3390/ijms25073717. 2024

Genotype and Allele Frequencies of Drug-Metabolizing Enzymes and Drug Transporter Genes Affecting Immunosuppressants in the Spanish White Population

Bosó V; (...); Aliño SF

Article. 10.1097/FTD.0b013e3182a94e65. 2014

Genotype FBN1/Phenotype relationship in a cohort of patients with Marfan syndrome.

Hernándiz A; (...); Sepúlveda P

Article. 10.1111/cge.13879. 2020

Giant Cell Arteritis Subtypes: Data from the ARTESER Registry

De Miguel, Eugenio; (...); Blanco, Ricardo

Meeting Abstract. 2021

Giant Cell Arteritis-Polymyalgia Rheumatica Spectrum Disease: Relation with Neoplasms and Role as a Paraneoplastic Syndrome

Munoz Martinez, Pablo; (...); Roman-Ivorra, Jose A.

Meeting Abstract. 2024

Guide to Good Humanization Practices in Patients with Rare Diseases. who vadis

Poveda Andres, Jose Luis

Editorial Material. 2022

GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

Lopez-Isac, E; (...); ASIG

Article. 10.1038/s41467-019-12760-y. 2019

Haemodialysis significantly reduces serum levetiracetam levels inducing epileptic seizures: Case report

Company-Albir, MJ; (...); Poveda, JL

Article. 10.1111/jcpt.12568. 2017

Hazardous drugs levels in compounding area surfaces of Hospital Pharmacies Services: multicentric study

Valero-Garcia, S; (...); Spanish Hosp Pharmacy Units

Article. 10.7399/fh.10935. 2018

Hazardous drugs: new challenges, new opportunities.

Valero García S; (...); Poveda Andrés JL

Article. 10.7399/fh.2016.40.2.10462. 2016

Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study

Solana-Altabella, Antonio; (...); Martinez-Cuadron, David

Article. 10.3390/cancers14081921. 2022

Health-related quality of life in patients with systemic lupus erythematosus: a Spanish study based on patient reports

Ivorra, JAR; (...); Vivas-Consuelo, D

Article. 10.1007/s10067-019-04485-6. 2019

HEALTH-RELATED QUALITY OF LIFE MEASURES IN SPONDYLOARTHROPATY PATIENTS UNDER BIOLOGICAL THERAPIES IN REAL LIFE

Meeting Abstract. 10.1136/annrheumdis-2021-eular.2282. 2021

High incidence of pulmonary thromboembolism in hospitalized SARS-CoV-2 infected patients despite thrombo-prophylaxis.

El-Qutob D; (...); Carrera-Hueso FJ

Article. 10.1016/j.hrtlng.2022.02.003. 2022

HIGH LEVELS OF ANTI-U1RNP AND ANTI-SM IN MIXED CONNECTIVE TISSUE DISEASE PATIENTS

Meeting Abstract. 10.1136/annrheumdis-2018-eular.6402. 2018

Hospital pharmacy initiatives for improving the management of patients with congenital coagulopathies

Bruno Montoro-Ronsano, Jose; (...); Alberto Vella, Vincenzo

Article. 10.7399/fh.11729. 2022

Hospitalization budget impact during the COVID-19 pandemic in Spain.

Carrera-Hueso, F. J.; (...); Crespo-Palomo, C.

Article. 10.1186/s13561-021-00340-0. 2021

How can artificial intelligence optimize value-based contracting?

Poveda, Jose Luis; (...); Medrano, Ignacio H.

Letter. 10.1186/s40545-022-00475-3. 2022

Hyperparathyroidism in patients with low bone mineral density treated with zoledronic acid or denosumab.

Riesco-Bárcena C; (...); Román-Ivorra J

Article. 10.1016/j.medcli.2024.07.020. 2024

IL2 DECREASE AND INCREASE OF IL10 AND INF1A ARE ASSOCIATED TO CLINICAL ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOUSPATIENTS

Grau, E; (...); Roman, JA

Meeting Abstract. 10.1136/annrheumdis-2018-eular.6747. 2018

IL2 Decrease Is Associated to ANTI-DNA Positivity in Systemic LUPUS Erythematous Patients

Meeting Abstract. 2018

Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia

Megias-Vericat, JE; (...); Aliño SF

Article. 10.1080/10428194.2016.1231405. 2017

Impact of adherence on subcutaneous interferon beta-1a effectiveness administered by Rebismart (R) in patients with multiple sclerosis

Edo Solsona MD; (...); Poveda Andrés JL

Article. 10.2147/PPA.S127508. 2017

IMPACT OF ADHERENCE ON SUBCUTANEOUS INTERFERON BETA-1A EFFECTIVENESS ADMINISTERED BY REBISMART (R) IN PATIENTS WITH MULTIPLE SCLEROSIS

Edo-Solsona, M.; (...); Poveda-Andres, J.

Meeting Abstract. 10.1016/j.jval.2016.09.512. 2016

Impact of an antimicrobial stewardship program on critical haematological patients.

Ruiz-Ramos, J; (...); Ramirez, P

Article. 10.7399/fh.2017.41.4.10709. 2017

Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.

Megías-Vericat JE; (...); Montesinos P

Article. 10.1080/10428194.2020.1839650. 2020

IMPACT OF GENDER IN JAK INHIBITORS PRESCRIPTION: ANALYSIS FROM A SINGLE CENTER COHORT

Garcia, E. Grau; (...); Ivorra, J. A. Roman

Meeting Abstract. 10.1136/annrheumdis-2022-eular.3917. 2022

Impact of NADPH oxidase functional polymorphisms in acute myeloid leukemia induction chemotherapy

Megias-Vericat, JE; (...); Aliño SF

Article. 10.1038/tpj.2017.19. 2018

Impact of novel polymorphisms related to cytotoxicity of cytarabine in the induction treatment of acute myeloid leukemia

Megias-Vericat, JE; (...); Aliño SF

Article. 10.1097/FPC.0000000000000286. 2017

Impact of Single Nucleotide Polymorphisms (SNPs) on Immunosuppressive Therapy in Lung Transplantation

Ruiz J; (...); Aliño SF

Article. 10.3390/ijms160920168. 2015

Impact of the therapeutic positioning report in the P&R process in Spain: analysis of orphan drugs approved by the European Commission and reimbursed in Spain from 2003 to 2019

Badia X; (...); Hernández C

Article. 10.1186/s13023-020-01507-4. 2020

Impact of Transporter Genes Polymorphisms in Standard Induction of Acute Myeloid Leukemia

Meeting Abstract. 2015

Impact of voriconazole plasma concentrations on treatment response in critically ill patients

Ruiz, J; (...); Ramirez, P

Article. 10.1111/jcpt.12817. 2019

Implementation and results of a risk-sharing scheme for enzyme replacement therapy in lysosomal storage diseases

Edo-Solsona, MD, Vitoria-Minana, I, Poveda-Andres, JL

Article. 10.7399/fh.11262. 2020

IMPLEMENTATION OF A WEEKLY CONSULTATION OF EMERGENCY ROOM PATIENTS IN PATIENTS WITH RHEUMATIC AND MUSCULOSKELETAL DISEASES

Roman Ivorra, J. A.; (...); Ivorra Cortes, J.

Article. 10.1136/annrheumdis-2014-eular.5020. 2014

Implication of Haemodiafiltration Flow Rate on Amikacin Pharmacokinetic Parameters in Critically Ill Patients

Ruiz-Ramos, J; (...); Ramirez, P

Article. 10.1159/000478969. 2018

Incidence and clinical manifestations of giant cell arteritis in Spain: results of the ARTESER register.

Fernandez-Lozano, Delia; (...); Blanco, Ricardo

Article. 10.1136/rmdopen-2023-003824. 2024

Incidence and General Clinical Features of Giant Cell Arteritis in the ARTESER Multicenter Study

Sanchez-Costa, Jesus T.; (...); Blanco, Ricardo

Meeting Abstract. 2021

Incidence of Hyperparathyroidism in Patients with Osteoporosis Treated with Zoledronic Acid or Denosumab

Riesco Barcena, Carmen; (...); Roman Ivorra, Jose Andres

Meeting Abstract. 2023

Incompatibility of undiluted busulfan injection with a needle-free valve

Cueto-Sola, M; (...); Poveda-Andres, JL

Letter. 10.2146/ajhp140111. 2014

Increase of IL10 and IFNa2 Are Associated to Clinical Activity in Systemic Lupus Erythematous Patients

Grau Garcia, Elena; (...); Roman-Ivorra, Jose A.

Meeting Abstract. 2024

Increased hospital stay and allograft dysfunction in renal transplant recipients with Cyp2c19 AA variant in SNP rs4244285.

Bosó V; (...); Aliño SF

Article. 10.1124/dmd.112.047977. 2013

Increased interferon-1a, interleukin-10 and BLyS concentrations as clinical activity biomarkers in systemic lupus erythematosus.

Fernández Matilla M; (...); Román Ivorra JA

Article. 10.1016/j.medcli.2018.12.012. 2019

INCREASED LEVELS OF INTERFERON ALPHA AND INTERLEUKIN-10 AS CLINICAL ACTIVITY BIOMARKERS IN SYSTEMIC LUPUS ERYTHEMATOUS PATIENTS

Meeting Abstract. 10.1136/annrheumdis-2017-eular.4180. 2017

Individualization of prophylaxis with recombinant factor VIII in severe or moderate hemophilia A

Vericat, JEM; (...); Bonanad, S

Meeting Abstract. 2018

Individualized Prophylactic Treatment with Recombinant Factor VIII in Severe or Moderate Haemophilia a Patients. Association Between Pharmacokinetic Parameters and Clinical Variables

Megias-Vericat, Juan Eduardo; (...); Bonanad, Santiago

Meeting Abstract. 10.1182/blood.V128.22.3802.3802. 2016

INFECTIOUS SPONDYLODISCITIS: 7-YEAR ANALYSIS OF CLINICAL AND PROGNOSTIC VARIABLES IN A TERTIARY HOSPITAL

Fragio, J; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2018-eular.7272. 2018

Influence of ABCB1 polymorphisms upon the effectiveness of standard treatment for acute myeloid leukemia: A systematic review and meta-analysis of observational studies

Megías-Vericat JE; (...); Aliño SF

Review. 10.1038/tpj.2014.80. 2015

Influence of concomitant immunomodulators during maintenance therapy with Adalimumab in inflammatory bowel disease: looking for the ideal patient to use monotherapy

Bastida, G; (...); Nos, P

Meeting Abstract. 10.1093/ecco-jcc/jjy222.581. 2019

Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment

Megias-Vericat, JE; (...); Aliño SF

Article. 10.1080/10428194.2017.1323267. 2017

Influence of pharmacokinetic/pharmacodynamic ratio on vancomycin treatment response in paediatric patients with Staphylococcus aureus bacteremia.

Ruiz J; (...); Poveda JL

Article. 10.23736/S0026-4946.18.04978-2. 2018

Influence of polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia.

Megías-Vericat JE; (...); Montesinos P

Article. 10.1097/FPC.0000000000000431. 2021

Influence of Single Nucleotide Polymorphisms in Anthracycline Metabolism Pathway in Standard Induction of Acute Myeloid Leukemia

Meeting Abstract. 2015

Influence of the EULAR recommendations for the use of imaging in large vessel vasculitis in the diagnosis of giant cell arteritis: results of the ARTESER register

De Miguel, Eugenio; (...); Blanco, Ricardo

Article. 10.1136/rmdopen-2022-002507. 2022

Influence of the EULAR recommendations for the use of imaging in large vessel vasculitis in the diagnosis of giant cell arteritis: results of the ARTESER register (vol 8, e002507, 2022)

De Miguel, Eugenio; (...); Blanco, Ricardo

Correction. 10.1136/rmdopen-2022-002507corr1. 2023

Interdisciplinary recommendations document to improve adherence in patients with chronic inflammatory diseases: Adhing recommendations.

Bermejo San José F; (...); Sanromán-Álvarez L

Article. 10.7399/fh.2016.40.5.10180. 2016

Intraperitoneal vancomycin in neonates during peritoneal dialysis: A case report

Company-Albir, MJ; (...); Poveda, JL

Article. 10.1111/jcpt.12842. 2019

Intravitreal melphalan therapy for vitreous seeds in retinoblastoma: Implementation and outcomes of a new chemotherapy protocol.

Solana-Altabella A; (...); Poveda JL

Article. 10.1177/1078155220904410. 2020

Involvement of interleukin 6 in SARS-CoV-2 infection: siltuximab as a therapeutic option against COVID-19

Palanques-Pastor, T, Lopez-Briz, E, Andres, JLP

Article. 10.1136/ejhpharm-2020-002322. 2020

Is Belimumab Dose Optimization Possible in Patients with Systemic Lupus Erythematosus?: Analysis of This Therapeutic Strategy in a Large Multicenter Cohort of Patients from Spanish Rheumatology Departments

Altabas Gonzalez, Irene; (...); Rua-Figueroa, Inigo

Meeting Abstract. 2023

Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis.

Pozo-Rosich P; (...); Irimia P

Article. 10.1186/s10194-024-01747-w. 2024

Isavuconazole Pharmacokinetics in Critically Ill Patients: Relationship with Clinical Effectiveness and Patient Safety.

Martin-Cerezuela, Maria; (...); Ramirez Galleymore, Paula

Article. 10.3390/antibiotics13080706. 2024

JAK inhibitors in combination with anti-TNF drugs on difficult-to-treat chronic polyarthritis: a case series.

Leal S; (...); Román-Ivorra JA

Letter. 10.55563/clinexprheumatol/4ao14k. 2024

Label-free piezoelectric biosensor for prognosis and diagnosis of Systemic Lupus Erythematosus

do Nascimento NM; (...); Gimenez-Romero D

Article. 10.1016/j.bios.2016.11.004. 2017

LAUDES Study: impact of digital ulcers on hand functional limitation, work productivity and daily activities, in systemic sclerosis patients.

Castellví I; (...); Fonollosa V

Article. 10.1007/s00296-019-04436-z. 2019

LENGTHENING OF RECOMMENDED DOSE RANGE OF ANTI-TNF THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PERIPHERAL PSORIATIC ARTHRITIS IN REMISSION

Cornejo Piquer, C. Nunez; (...); Roman Lvorra, J. A.

Article. 10.1136/annrheumdis-2014-eular.4944. 2014

LONG-TERM FOLLOW-UP OF 214 PRIMARY RAYNAUD' S PHENOMENON PATIENTS

Meeting Abstract. 10.1136/annrheumdis-2018-eular.6318. 2018

LONG-TERM FOLLOW-UP OF PRIMARY RAYNAUD'S PHENOMENON COHORT OF 248 PATIENTS

Meeting Abstract. 10.1136/annrheumdis-2019-eular.5989. 2019

Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice.

Bykerk VP; (...); Sibilia J

Article. 10.1007/s10067-019-04535-z. 2019

LUPUS NEPHRITIS RESPONSE IN TERMS OF KIDNEY FUNCTION, URINE SEDIMENT AND SEROLOGICAL ACTIVITY AFTER SUBCUTANEOUS BELIMUMAB TREATMENT

De la Rubia Navarro, M.; (...); Ivorra, J. A. Roman

Meeting Abstract. 10.1136/annrheumdis-2022-eular.2944. 2022

Management of flexible cavovarus foot in patients with Charcot-Marie-Tooth disease: midterm results.

Megías-Vericat JE; (...); Poveda-Andrés JL

Article. 2021

Manipulación de fármacos para su administración por gastrostomía endoscópica percutánea en pacientes con esclerosis lateral amiotrófica y nutrición enteral.

Vázquez Polo A; (...); Vázquez Costa JF

Article. 10.20960/nh.03946. 2022

Matching-Adjusted Indirect Comparison of Efficacy and Consumption of rVIII-SingleChain Versus Two Recombinant FVIII Products Used for Prophylactic Treatment of Adults/Adolescents with Severe Haemophilia A

Bonanad, S; (...); Santos, S

Article. 10.1007/s12325-021-01853-0. 2021

Meta-analysis and systematic review of the effect of the donor and recipient CYP3A5 6986A>G genotype on tacrolimus dose requirements in liver transplantation.

Rojas LE; (...); Aliño SF

Article. 10.1097/FPC.0b013e3283642fb3. 2013

Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches.

Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor

Article. 10.3390/cancers14030596. 2022

Methotrexate in patients with rheumatoid arthritis in Spain: Subanalysis of the AR Excellence project.

Tornero-Molina J; (...); Sanchez-Alonso F

Article. 10.1016/j.reuma.2017.11.007. 2019

Metyrapone as treatment in the neonatal McCune-Albright syndrome

de Mingo, Carmen; (...); Garcia-Robles, Ana

Article. 10.1515/jpem-2020-0036. 2020

Migratory arthralgia as the initial sign of systemic toxicity associated with chronic nitrofurantoin treatment.

Arevalo Ruales, Karla; (...); Martinez Frances, Manuela

Letter. 10.1016/j.reuma.2018.07.006. 2018

Monitoring coagulation factors during surgery. A systematic review

Eduardo Megias-Vericat, Juan; (...); Luis Poveda-Andres, Jose

Review. 10.7399/fh.11766. 2021

Monitoring contamination of hazardous drug compounding surfaces at hospital pharmacy departments. A consensus Statement. Practice guidelines of the Spanish Society of Hospital Pharmacists (SEFH).

Valero-García S; (...); Delgado-Sánchez O

Article. 10.7399/fh.11655. 2021

Monitoring the quality of the hospital pharmacoterapeutic process by sentinel patient program.

Fernandez-Megia, MJ; (...); Poveda Andrés JL

Article. 10.7399/fh.10793. 2018

Mortality in Patients with Giant Cell Arteritis in Spain: Results from the ARTESER Registry

Molina-Collada, Juan; (...); Blanco-Alonso, Ricardo

Meeting Abstract. 2024

Mortality in patients with giant cell arteritis in Spain: results from the ARTESER registry

Molina-Collada, Juan; (...); ARTESER Project Collaborative Grp, Clara

Article. 10.1186/s13075-024-03468-6. 2025

Multidisciplinary consensus on the use of hydroxychloroquine in patients with systemic lupus erythematosus

Rua-Figueroa, Inigo; (...); Calvo Alen, Jaime

Article. 10.1016/j.reuma.2024.03.005. 2024

Multi-Omic Approaches to Breast Cancer Metabolic Phenotyping: Applications in Diagnosis, Prognosis, and the Development of Novel Treatments

Gomez-Cebrian, N; (...); Pineda-Lucena, A

Review. 10.3390/cancers13184544. 2021

Musculoskeletal Manifestations in Patients Diagnosed with Marfan Syndrome

Mas Sanchez, Laura; (...); Roman-Ivorra, Jose A.

Meeting Abstract. 2024

N. VICTOR JIMENEZ TORRES (1942-2015) IN MEMORIAM

Climente Martí M, Poveda Andrés JL, Culebras J

Biographical-Item. 10.3305/nh.2015.32.4.9704. 2015

National Survey of the SEFH-2019: portfolio of services, healthcare activity, teaching and research in Hospital Pharmacy Services in Spain (vol 45, pg 32, 2021)

Perez-Encinas, Montserrat; (...); Angel Calleja-Hernandez, Miguel

Correction. 10.7399/fh.11740. 2021

National Survey on the Use of Mobile Applications in Patients with Hemophilia and Other Coagulopathies

Eduardo Megias, Juan; (...); Poveda Andres, Jose Luis

Meeting Abstract. 10.1182/blood-2022-169938. 2022

New challenges of advanced therapies.

Megías-Vericat JE; (...); Poveda Andrés JL

Article. 10.1016/j.farma.2023.11.008. 2024

New structural insights into the role of TROVE2 complexes in the on-set and pathogenesis of systemic lupus erythematosus determined by a combination of QCM-D and DPI.

Juste-Dolz A; (...); Maquieira Á

Article. 10.1007/s00216-018-1407-x. 2019

Non-adherence to subcutaneous biological medication in patients with rheumatoid arthritis: a multicentre, non-interventional study

Calvo-Alen, J; (...); Marras, C

Article. 2017

Novel Blood Biomarkers for Response Prediction and Monitoring of Stereotactic Ablative Radiotherapy and Immunotherapy in Metastatic Oligoprogressive Lung Cancer.

Zafra J; (...); Barragán I

Article. 10.3390/ijms25084533. 2024

Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus

Solana-Altabella, Antonio; (...); Poveda-Andres, Jose Luis

Article. 10.1097/MD.0000000000032208. 2022

ODs with a positive TPR conclusion, not subject to a conditional approval, and approved without requering a pass would be more likely to be reimbursed in Spain.

Poveda JL; (...); Badia X

Article. 10.1186/s13023-022-02610-4. 2023

Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes

Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor

Review. 10.3390/biology12091159. 2023

Online course of pharmacokinetic monitoring in hemophilia with application in the clinical practice

Bonanad, S; (...); Poveda, JL

Meeting Abstract. 2018

Optimization of Tocilizumab Therapy in Giant Cell Arteritis: A Multicenter Real Life Study of 134 Patients

Calderon-Goercke, Monica; (...); Blanco, Ricardo

Meeting Abstract. 2019

OPTIMIZING MANAGEMENT AND OUTCOMES OF ACTIVATED PHOSPHOINOSITIDE 3-KINASE DELTA SYNDROME (APDS) IN SPAIN: BEWAYAPDS PROJECT

Flores-Moreno, S.; (...); Gil, A.

Meeting Abstract. 2024

OXIDATIVE STRESS LEVELS ARE INCREASED IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH A HIGHER ACCUMULATIVE DAMAGE SCORE

Grau Garcia, E.; (...); Roman Ivorra, J.

Meeting Abstract. 10.1136/annrheumdis-2016-eular.3183. 2016

Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol

Garcia-Robles, Ana; (...); Carrascosa, MA

Article. 10.3389/fped.2020.00372. 2020

Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol (vol 8, 372, 2020)

Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta

Correction. 10.3389/fped.2021.834454. 2022

Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project

Morillo-Verdugo, R; (...); Diaz-Olmo, J

Article. 10.7399/fh.11719. 2021

Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project.

Morillo-Verdugo R; (...); Díaz-Olmo J

Article. 2021

Patient Decision Aid (PDA) for Patients with Rheumatoid Arthritis Reduces Decisional Conflict and Improves Readiness for Treatment Decision Making.

Pablos JL; (...); Lizán L

Article. 10.1007/s40271-019-00381-y. 2020

Pharmaceutical care to hospital outpatients during the COVID-19 pandemic. Telepharmacy

Margusino-Framiñán L; (...); Morillo-Verdugo R

Article. 10.7399/fh.11498. 2020

Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic Review.

Ballesta-Lopez, Octavio; (...); Poveda-Andres, Jose Luis

Article. 10.3390/ijms26041760. 2025

Pharmacogenetics of Metabolic Genes of Anthracyclines in Acute Myeloid Leukemia

Megias-Vericat, JE; (...); Montesinos, P

Review. 10.2174/1389200218666171101124931. 2018

Pharmacogenomics and the treatment of acute myeloid leukemia

Megías-Vericat JE; (...); Aliño SF

Review. 10.2217/pgs-2016-0055. 2016

Pharmacometabolomics by NMR in Oncology: A Systematic Review.

Gómez-Cebrián N; (...); Pineda-Lucena A

Article. 10.3390/ph14101015. 2021

Pharmacotherapeutic management of advanced therapy medicinal products

Luis Poveda-Andres, Jose; (...); Valero-Garcia, Silvia

Article. 10.7399/fh.13036. 2022

Pharmacotherapy follow-up of patients under treatment with biologic agents for chronic inflammatory systemic conditions: an agreement among hospital pharmacists for the standardized collection of a minimum set of data.

Calleja Hernández MÁ; (...); Aragon, B

Article. 10.7399/fh.2017.41.1.10463. 2017

Physical Activity In Haemophilia: Hemorrhagic Risk And Factor Levels (myPKFiT)

Querol-Fuentes, F; (...); Bonanad, S

Meeting Abstract. 2017

Pilot evaluation of home delivery programme in haemophilia

Megias-Vericat, JE; (...); Poveda-Andres, JL

Article. 10.1111/jcpt.12718. 2018

PK-GUIDED SWITCH BETWEEN STANDARD HALF-LIFE AND EXTENDED HALF-LIFE FACTOR VIII PRODUCTS

Vericat, JEM; (...); Iorio, A

Meeting Abstract. 2020

Points to Consider in the Foundation of Multidisciplinary Units for Psoriatic Arthritis: A Delphi Study and a Systematic Review of the Literature

Gratacos-Masmitja, J; (...); Lopez-Estebaranz, JL

Review. 10.1007/s12325-016-0429-z. 2017

Positive impact of ABCB1 polymorphisms in overall survival and complete remission in acute myeloid leukemia: a systematic review and meta-analysis

Megías-Vericat JE; (...); Aliño SF

Letter. 10.1038/tpj.2015.79. 2016

Practice guidelines for the use of subcutaneous abatacept.

Mola EM; (...); Carmona L

Article. 10.1016/j.reuma.2013.11.006. 2014

Pre and post intervention study of antiblastic drugs contamination surface levels at a Pharmacy Department Compounding Area using a closed system drug transfer device and a decontamination process

Valero, S; (...); Poveda, JL

Article. 10.1016/j.yrtph.2018.03.001. 2018

PREDICTIVE MODEL FOR SHOULDER PAIN USING CLINICAL AND EPIDEMIOLOGICAL VARIABLES

Olmos, CF; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2017-eular.6010. 2017

PRELIMINAR STUDY OF THERAPY ADHERENCE CONTROLLED BY PRESCRIPTION OF MEDICATION AND SELF-PERCEPTION ADHERENCE OF INFLAMMATORY CHRONIC DISEASE PATIENTS

Meeting Abstract. 10.1136/annrheumdis-2019-eular.5937. 2019

Preparación y administración de perfusiones de insulina en neonatología: Encuesta nacional.

García-Robles A; (...); Aguar-Carrascosa M

Letter. 10.1016/j.anpedi.2020.06.008. 2021

Preparation and administration of insulin infusions in neonatology: A national survey.

Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta

Article. 10.1016/j.anpede.2020.06.015. 2021

Presence of good humanization practices in the healthcare of patients with rare diseases in Pharmacy Services

Company Albir MJ, Poveda Andrés JL, Edo Solsona MD

Article. 10.1016/j.farma.2023.06.0131130. 2024

Prevalence and clinical characteristics of patients with rheumatoid arthritis with interstitial lung disease using unstructured healthcare data and machine learning

Román Ivorra JA; (...); Castellanos-Moreira R

Article. 10.1136/rmdopen-2023-003353. 2024

PREVALENCE AND COMORBIDITIES OF RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE IN SPAIN: A RETROSPECTIVE ANALYSIS OF ELECTRONIC HEALTH RECORDS USING NATURAL LANGUAGE PROCESSING

Roman Ivorra, J. A.; (...); Lujan Valdes, S.

Meeting Abstract. 10.1136/annrheumdis-2022-eular.5042. 2022

PREVALENCE OF HEPATITIS B AND C INFECTION AND REACTIVATION IN PATIENTS RECEIVING BIOLOGIC IV THERAPIES

Ruales, KA; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2017-eular.4827. 2017

PREVALENCE, DIAGNOSTIC DELAY AND TREATMENT PROFILE OF PATIENTS WITH MONOGENIC AUTOINFLAMMATORY DISEASES IN AN ADULT RHEUMATOLOGY SERVICE OF A TERTIARY HOSPITAL.

Perales, C. Pavez; (...); Ivorra, J. A. Roman

Meeting Abstract. 10.1136/annrheumdis-2022-eular.4143. 2022

Proactive therapeutic drug monitoring and pharmacogenetic analysis in inflammatory bowel disease: A systematic review

Ballesta-Lopez, Octavio; (...); Luis Poveda-Andres, Jose

Review. 10.7399/fh.11780. 2021

PROFILE OF REAL WORLD AXIAL SPONDYLOARTHRITIS PATIENTS REFRACTORY TO ADVANCED THERAPY

Alcantara Alvarez, I; (...); Roman Ivorra, J. A.

Meeting Abstract. 2024

PROFILE OF REFRACTORY RA PATIENTS FOR TARGETED THERAPIES IN REAL LIFE

Garcia, E. Grau; (...); Ivorra, J. A. Roman

Meeting Abstract. 10.1136/annrheumdis-2023-eular.4014. 2023

Prognostic Impact of Anthracycline Metabolism Gene Polymorphisms in Newly Diagnosed Acute Myeloid Leukemia Adults

Article. 2014

Prognostic Impact of Cytarabine Pathway Gene Polymorphisms in Acute Myeloid Leukemia Adults Undergoing Induction Chemotherapy

Article. 2014

PROGNOSTIC IMPACT OF TRANSPORTER GENE POLYMORPHISMS IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA ADULTS

Megias Vericat, J. E.; (...); Sanz, M. A.

Article. 2015

PROSPECTIVE STUDY OF 24 MONTHS OF EVOLUTION OF A COHORT OF PATIENTS WITH RHUPUS

Cordellat, I. Martinez; (...); Ivorra, J. A. Roman

Meeting Abstract. 10.1136/annrheumdis-2022-eular.3898. 2022

PROSPECTIVE STUDY OF BONE METABOLISM AND FRACTURE INCIDENCE IN SPINAL CORD INJURY PATIENTS DURING A PERIOD OF 24 MONTHS

Cordellat, IM; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2019-eular.5953. 2019

Prostaglandin Injection After Arterial Compromise Related to Hyaluronic Acid Filler

Letter. 10.1097/DSS.0000000000001046. 2017

Pseudogout in a patient with bilateral total knee prosthesis: A challenging diagnosis

Escriva-Fornes, M; (...); Ivorra-Cortes, J

Letter. 10.1016/j.jbspin.2015.05.015. 2016

PULMONARY FUNCTION IN PATIENTS DIAGNOSED OF EARLY SYSTEMIC SCLEROSIS: 10 YEARS EXPERIENCE.

Ortiz-Sanjuan, F.; (...); Ivorra, J. A. Roman

Meeting Abstract. 10.1136/annrheumdis-2022-eular.3085. 2022

PULMONARY FUNCTION IN PATIENTS DIAGNOSED OF EARLY SYSTEMIC SCLEROSIS: A NEW TOOL FOR SYSTEMIC SCLEROSIS CLASIFFICATION?

Meeting Abstract. 10.1136/annrheumdis-2020-eular.4423. 2020

PULMONARY INVOLVEMENT AND FUNCTIONAL LIMITATION IN SYSTEMIC SCLEROSIS

Rodriguez, JEO; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2019-eular.6576. 2019

Pulmonary venous thrombosis secondary to radiofrequency ablation of the pulmonary veins.

Lopez-Reyes, R; (...); Nauffal, D

Article. 10.1016/j.rmcr.2017.11.008. 2018

Pyogenic Vertebral Osteomyelitis: Outcome Variables Analysis in a 116 Patients Cohort at a Tertiary Hospital during the Last 8 YEARS

Gil, JJF; (...); Ivorra, JAR

Meeting Abstract. 2018

Quality standards in a rheumatology Day-Care Hospital Unit. The proposal of the Spanish Society of Rheumatology Day Hospitals' Working Group.

Garcia-Vicuna R; (...); Loza E

Article. 10.1016/j.reuma.2014.02.008. 2014

Quantification of physical activity in adult patients with haemophilic arthropathy in prophylaxis treatment using a fitness tracker

Perez-Alenda, S; (...); Querol, F

Letter. 10.1111/hae.13388. 2018

REAL LIFE SAFETY AND SURVIVAL OF TARGETED THERAPIES IN ARTHRITIS PATIENTS OVER AGE OF 65

Grau Garcia, E.; (...); Roman Ivorra, J. A.

Meeting Abstract. 10.1136/annrheumdis-2023-eular.3018. 2023

Real World Data on Antifibrotics in Rheumatoid Arthritis-Interstitial Lung Disease. National Multicenter Study of 73 Patients

Atienza-Mateo, Belen; (...); Blanco, Ricardo

Meeting Abstract. 2023

Real-world Effectiveness and Safety of JAK Inhibitors in Rheumatoid Arthritis: A Single-centre Study

Gonzalez Mazario, Roxana; (...); Roman Ivorra, Jose Andres

Article. 10.1016/j.reuma.2021.08.001. 2022

Real-world Effectiveness and Safety of JAK Inhibitors in Rheumatoid Arthritis: A Single-centre Study.

González Mazarío R; (...); Román Ivorra JA

Article. 10.1016/j.reumae.2021.08.004. 2022

Real-world evidence of tofacitinib in rheumatoid arthritis patients in Spain

Roman Ivorra, Jose A., Llevat, Noelia, Montoro, Maria

Article. 10.5582/ddt.2022.01028. 2022

Recommendations for the use of parenteral methotrexate in rheumatic diseases.

Molina, JT; (...); de Salazar, JRG

Article. 10.1016/j.reuma.2016.12.001. 2018

Red flags for clinical suspicion of eosinophilic granulomatosis with polyangiitis (EGPA).

Solans-Laque, R; (...); Cid, M C

Article. 10.1016/j.ejim.2024.06.008. 2024

Reduced Diffusion Capacity in COVID-19 Survivors.

Mendez, Raul; (...); Menendez, Rosario

Article. 10.1513/AnnalsATS.202011-1452RL. 2021

Reduction in alert fatigue in an assisted electronic prescribing system, through the Lean Six Sigma methodology.

Cuéllar Monreal MJ; (...); Poveda Andrés JL

Article. 10.7399/fh.2017.41.1.10434. 2017

Refractory RA Patients for Targeted Therapies in Real Life

Grau Garcia, Elena; (...); Roman Ivorra, Jose Andres

Meeting Abstract. 2023

RELATION BETWEEN ACCUMULATIVE DAMAGE AND DISABILITY RECOGNICED BY THE INSS* IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS

Grau Garcia, E.; (...); Roman Ivorra, J.

Meeting Abstract. 10.1136/annrheumdis-2016-eular.4100. 2016

Relation Between Cumulative Damage in Systemic Lupus Erythematosus and Recognised Disability by the National Social Security Institute of Spain (INSS).

Fernández Matilla M; (...); Román Ivorra JA

Article. 10.1016/j.reuma.2019.03.003. 2019

Relationship between structural damage with loss of strength and functional disability in psoriatic arthritis patients.

Feced Olmos CM; (...); Román Ivorra JA

Article. 10.1016/j.clinbiomech.2019.06.009. 2019

RESPONSE OF BEHCET'S REFRACTORY ORAL AND/OR GENITAL ULCERS TO APREMILAST IN COMBINATION VS MONOTHERAPY. NATIONAL MULTICENTER STUDY OF 51 CASES OF CLINICAL PRACTICE

Morant, AH; (...); Blanco, R.

Meeting Abstract. 10.1136/annrheumdis-2020-eular.6246. 2020

RESULTS IN THE FOLLOW-UP OF THE NURSING CONSULTATION FOR THE MONITORING OF RHEUMATOLOGIC PATIENTS TREATED WITH INTRAVENOUS THERAPIES

Herranz, CN; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2017-eular.5702. 2017

RESULTS OF EARLY INTERVENTION IN PATIENTS BEING OFF WORK DUE TO MUSCULOSKELETAL CAUSES IN THE HUP LA FE AREA

Molina Almela, C.; (...); Roman Ivorra, J. A.

Article. 10.1136/annrheumdis-2014-eular.5060. 2014

RHEUMATOID ARTHRITIS AND INTERSTITIAL LUNG DISEASE. MULTICENTRIC RETROSPECTIVE STUDY OF 118 PATIENTS TREATED WITH BIOLOGICAL NO ANTI TNF

Fernandez-Diaz, C; (...); Blanco, R

Meeting Abstract. 10.1136/annrheumdis-2018-eular.4986. 2018

Rhupus syndrome: Description of 9 cases with special attention to the HLA-DR genotype

Hurtado, Andres Perez; (...); Ivorraa, Jose Andres Roman

Article. 10.1016/j.medcli.2024.09.006. 2025

RITUXIMAB SAFETY AND PERSISTENCE IN PATIENTS WITH SYSTEMIC AUTOIMMUNE DISEASES

Perales, CP; (...); Ivorra, JAR

Meeting Abstract. 2020

Salvage therapy with topical posaconazole in lung transplant recipients with invasive Scedosporium infection.

Sole, A; (...); Peman, J

Article. 10.1111/ajt.14580. 2018

SCORE2 Is Superior to SCORE in Predicting the Presence of Carotid Plaques and Intima-media Thickness in Rheumatoid Arthritis Patients: A Cross-sectional Study with Carotid Ultrasound

Campos Fernandez, Cristina; (...); Roman-Ivorra, Jose A.

Meeting Abstract. 2024

SECONDARY PREVENTION OF VERTEBRAL FRACTURES SUSTAINED EFFICACY OVER TIME

Oller Rodriguez, J. E.; (...); Roman Ivorra, J. A.

Meeting Abstract. 10.1136/annrheumdis-2022-eular.3312. 2022

SEFH National Survey-2019: general characteristics, staffing, material resources and information systems in Spain's hospital pharmacy departments.

Pérez-Encinas M; (...); Calleja-Hernández MÁ

Article. 10.7399/fh.11565. 2020

Selective ophthalmic intra-arterial melphalan therapy for advanced retinoblastoma: implementation and outcomes of a new chemotherapy protocol.

Valero García S; (...); Poveda Andrés JL

Article. 10.1177/1078155212457964. 2013

Serological Evidence of SARS-CoV-2 in Symptomatic Patients Under Biological Treatment in a Rheumatology Service

Perales, CP; (...); Ivorra, JAR

Meeting Abstract. 2020

Serum Adalimumab Levels Predict Successful Remission and Safe Deintensification in Inflammatory Bowel Disease Patients in Clinical Practice

Aguas Peris M; (...); Nos, P

Article. 10.1097/MIB.0000000000001182. 2017

Serum adalimumab levels predict successful remission and safe de-intensification in inflammatory bowel disease patients in clinical practice

Aguas, M; (...); Nos, P

Meeting Abstract. 2017

Sex Differences in Giant Cell Arteritis: Data from the ARTESER Registry

Fernandez-Lozano, Delia; (...); Blanco, Ricardo

Meeting Abstract. 2023

Short and Long-Term Follow-up with Tocilizumab in Giant Cell Arteritis. National Multicenter Study of 49 Patients of Clinical Practice

Dom-Nguez-Casas, LC; (...); Blanco, R

Meeting Abstract. 2017

Single Nucleotide Polymorphisms, SNPs, Associated With the Efficacy and Security of Immunosuppressive Treatment in Heart Transplantation

Sanchez-Lazaro, I.; (...); Salvador-Sanz, A.

Article. 10.1016/j.healun.2014.01.392. 2014

SMPTall man lettering application in medication information systems as a quality and safety strategy in hospital organization

Iglesias Gomez, Ruben; (...); Poveda Andres, Jose Luis

Article. 10.1111/jcpt.13703. 2022

SNPs and taxane toxicity in breast cancer patients

Bosó V; (...); Aliño SF

Article. 10.2217/PGS.14.127. 2014

Spanish Consensus on the Prevention and Treatment of Pseudomonas aeruginosa Bronchial Infections in Cystic Fibrosis Patients

Cantón R; (...); Solé A

Article. 10.1016/j.arbres.2014.09.021. 2015

Spanish Rheumatology Society and Hospital Pharmacy Society Consensus on recommendations for biologics optimization in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis

González-Álvaro I; (...); Spanish Rheumatology Society

Article. 10.1093/rheumatology/keu461. 2015

Standards of care and quality indicators for multidisciplinary care models for psoriatic arthritis in Spain

Gratacos, J; (...); Queiro, R

Article. 10.1007/s00296-018-3986-4. 2018

Study of Bone Metabolism in Patients Diagnosed with Osteogenesis Imperfecta

Ramos Castro, Daniel; (...); Roman-Ivorra, Jose A.

Meeting Abstract. 2024

Study on the Linezolid Prescription According to the Approval of Indication in a University Hospital

Pérez-Cebrián M; (...); Llopis-González A

Article. 2015

Sustained Drug-Free Remission in Giant Cell Arteritis.

Narvaez, Javier; (...); Blanco, Ricardo

Article. 10.1093/rheumatology/keae644. 2024

Sustained Drug-free Remission in Giant Cell Arteritis: Results Results of the Spanish ARTESER Registry

Narvaez-Garcia, Javier; (...); Blanco-Alonso, Ricardo

Meeting Abstract. 2024

Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia

Megías-Vericat JE; (...); Montesinos P

Review. 10.3390/pharmaceutics14040878. 2022

SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH POSITIVES AUTOANTIBODIES WITH REMISSION OR LOW ACTIVITY EXHIBIT BOTH LOWER INTERFERON ALPHA AND INTERLEUKIN-10 LEVELS